📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Systems biology-enabled targeting of NF-?? and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL. (2024)

First Author: Vareli A

Attributed to: Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2024.11.30.626166

Publication URI: http://dx.doi.org/10.1101/2024.11.30.626166

Type: Preprint